The global oligonucleotide synthesis market is expected to reach USD
2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%.

The growth of this market is mainly driven by the increasing research
activities in the pharma and biotech sectors and the rising demand for
innovative diagnostic and therapeutic techniques.

This report segments the market into product, application, end user, and
region. Based on product, the market is segmented into synthesized
oligonucleotides, reagents, and equipment. In 2017, synthesized
oligonucleotides are estimated to account for the largest share of the
total market, followed by reagents. The growth of the synthesized
oligonucleotides segment is attributed to the increasing number of
applications of synthesized oligonucleotides in research, diagnostics,
and therapeutics.

Market Dynamics

Drivers

Increasing Use of Synthesized Oligonucleotides in Molecular
Diagnostics and Clinical Applications

Increasing Government Investments and R&D Expenditure in
Pharmaceutical and Biotechnology Companies